Left ventricular hypertrophy in hypertension

Establishment of a prediction model of changing trends in cardiac hypertrophy disease based on microarray data screening

The aim of the present study was to construct a mathematical model to predict the changing trends of cardiac hypertrophy at gene level. Microarray data were downloaded from Gene Expression Omnibus database (accession, GSE21600), which included 35 samples harvested from the heart of Wistar rats on postoperative days 1 (D1 group), 6 (D6 group) and 42 (D42 group) following aorta ligation and sham operated Wistar rats, respectively. Each group contained six samples, with the exception of the samples harvested from the aorta ligated group after 6 days, where n=5. Differentially expressed genes (DEGs) were identified using a Limma package in R. Hierarchical clustering analysis was performed on common DEGs in order to construct a linear equation between the D1 and D42 groups, using linear discriminant analysis. Subsequent verification was performed using receiver operating characteristic (ROC) curve and the measurement data at day 42. A total of 319, 44 and 57 DEGs were detected in D1, D6 and D42 sample groups, respectively. AKIP1, ANKRD23, LTBP2, TGF-β2 and TNFRSF12A were identified as common DEGs in all groups. The predicted linear equation between D1 and D42 group was calculated to be y=1.526×-186.671. Assessment of the ROC curve demonstrated that the area under the curve was 0.831, with a specificity and sensitivity of 0.8. As compared with the predictive and measurement data at day 42, the consistency of the two sets of data was 76.5%. In conclusion, the present model may contribute to the early prediction of changing trends in cardiac hypertrophy disease at gene level.

Relationship between left ventricular mass and serum cholesterol level in the untreated hypertensive

OBJECTIVE

To study the relationship between serum cholesterol level and left ventricular mass for a population of untreated hypertensive patients.

DESIGN

A cross-sectional study.

PATIENTS

We studied 273 untreated hypertensive patients without associated diseases consecutively referred for evaluation of blood pressure. All patients underwent M-mode echocardiographic assessment of left ventricular mass, office blood pressure measurement and 24 h ambulatory blood pressure monitoring. Fasting plasma glucose and total cholesterol levels were measured on the same day.

RESULTS

We found a weak but significant correlation (r = 0.20-0.26, P < 0.01) between serum cholesterol level and left ventricular wall thickness or left ventricular mass irrespective of the mode of indexation used (height, height2.7 and body surface area). In multivariate analysis this relation remained significant after introduction of sex, age, weight, height, blood pressure and blood glucose level. When data for men and women were analysed separately the relationship between left ventricular mass and cholesterol remained significant for men only.

CONCLUSION

There is a significant and independent positive relationship between serum cholesterol level and left ventricular mass that could contribute to the prognostic value of left ventricular hypertrophy.

Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death

BACKGROUND

Epidemiological studies have shown that hypertension and left ventricular hypertrophy (LVH) increase the risk of sudden cardiac death (SCD) in patients with severe coronary artery disease (CAD). However, autopsy studies comparing the morphological substrates for SCD in normotensives and hypertensives are lacking.

METHODS AND RESULTS

Heart weight and coronary plaque morphology were prospectively compared in SCD in 36 hypertensive and 63 normotensive individuals. The frequency of CAD was similar in hypertensives (69%, n = 25) and normotensives (73%, n = 46). In 71 hearts with CAD, acute coronary thrombi were present in 76% of normotensives versus 36% of hypertensives (P = .002), LVH was present in 64% of hypertensives versus 33% of normotensives (P = .01) and in 72% of hypertensives with one-vessel disease versus 17% of normotensives with one-vessel disease (P = .0005), and a healed or acute infarct without acute thrombus was present in 36% of hypertensives versus 9% of normotensives (P = .007). Heart weight was higher in all cases of plaque rupture (519 +/- 109 g) than eroded plaque (381 +/- 92 g, P = .0002). In contrast to hypertensives, normotensive hearts with severe CAD showed a stepwise increase in heart weight with one-, two-, and three-vessel disease (P = .01).

CONCLUSIONS

Severe CAD is present in most SCD in hypertensive and normotensive individuals, but acute thrombi are more common in normotensives. LVH is an important contributing mechanism of SCD in hypertensives, especially in cases of one-vessel disease. LVH is associated with plaque rupture and extent of disease in SCD in normotensives with severe CAD.

Hypertension and left ventricular hypertrophy: is drug therapy beneficial?

Left ventricular hypertrophy (LVH) is a consequence of long-standing hypertension and is considered to be an independent risk factor for cardiovascular morbidity and mortality. Several antihypertensive agents are capable of inducing regression of LVH, but it is not known which class of drugs is most effective. The impact of drug-induced reversal of hypertrophy on ventricular function remains a controversial issue. Furthermore, the long-term clinical benefits of LVH regression have yet to be documented. Controversies also exist regarding the clinical outcomes associated with drug-induced LVH regression.

The Bergen Blood Pressure Study: blood pressure changes, target organ damage and mortality in subjects with high and low blood pressure over 27 years

Based on the Bergen population screening in 1963-64, 344 married couples (688 subjects), then aged 30-69 years, were included for studies in families with a history of hypertension or normotension. In 1990 430 subjects were available to a follow-up examination. The present paper describes 27-year mortality, blood pressure (BP) changes, cardiovascular disease and target organ damage in this population. In males who were hypertensive by the 1963-64 screening BP, the all-cause 27-year mortality was three times higher than in initially normotensive males (p < 0.05). From 1963-64 to 1990, the systolic BP was generally increased, whereas the diastolic BP was decreased in initially hypertensive and increased in initially normotensive subjects. In subjects who were hypertensive in 1963-64, the relative risk of hypertension in 1990 was more than seven times higher than in initially normotensive subjects (p < 0.05), cardiovascular events were reported more often (p < 0.001), and the mean electrocardiographic left ventricular voltage was higher (p < 0.01). Proteinuria was more frequent in initially hypertensive than normotensive males (p < 0.01). In summary, hypertension defined by a single BP recording at the 1963-64 screening was a risk factor for hypertension, cardiovascular morbidity and, for males, all-cause mortality 27 years later. With respect to offspring studies, our findings substantiate the classification of hypertensive and normotensive families. From 1963-64 to 1990, the BP status had changed in several couples, and the long observation period seems mandatory if a reliable definition of the family history of hypertension or normotension is to be obtained.